Centerspace
NYSE:CSRREIT - Residential
-$0.16 today
- Market cap
- $944.16M
- Beta
- 0.89
- P/E (TTM)
- 110.2
- EPS (TTM)
- $0.50
- Dividend yield
- 5.63%
Volume 0.16M
Average 0.15M
CSR Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
CenterspaceNYSE: CSR
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q1 FY2026 capital expenditures of $5.32M (cash outflow) rose 5.4% year over year, ahead of the -13.7% change in trailing-twelve-month capital expenditures. Sequentially, it fell 47.1% from the prior quarter. Over 3 fiscal years it compounded at -15.5% a year.
Context
- Capital expenditures amounted to 9.7% of revenue in FY2025, down 12.0 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +5.4% holds above the trailing-twelve-month pace of -13.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (34.16M) USD
- Year-over-year change
- +39.7%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (34.16M) | +39.7% |
| FY2024 | 2024-12-31 | (56.65M) | +3.7% |
| FY2023 | 2023-12-31 | (58.83M) | -4.0% |
| FY2022 | 2022-12-31 | (56.57M) | -57.7% |
| FY2021 | 2021-12-31 | (35.88M) | — |
Capital Expenditures vs competitors
How CSR compares with its peers on the latest reported figures
- CSR's LTM Mar 2026 capital expenditures of $34.44M is the 4th largest of the 9 companies compared; the peer median is $15.32M.
- Its year-over-year change of -13.7% is the 5th highest of 7, against a peer median of +15.3%.
- Capital expenditures amounts to 12.7% of revenue for CSR, versus a peer median of 2.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $219.11M | +58.5% | -25.1% | 178.8% | |
| LTM Mar 2026 | $155.89M | -24.2% | +9.0% | 27.6% | |
| LTM Mar 2026 | $103.46M | +36.9% | -45.1% | 13.5% | |
| LTM Mar 2026 | $34.44M | -13.7% | -15.5% | 12.7% | |
| LTM Mar 2026 | $21.29M | -6.3% | +3.0% | 2.6% | |
| LTM Mar 2026 | $9.35M | -148.6% | — | 3.2% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | +100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CSR) | $15.32M | +15.3% | -11.1% | 2.9% | |
Competitors are the stored peer set for CSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (2.1M) | (17.64M) | 41.97M | (14.19M) | (2.41M) |
| Depreciation & Amortization | 93.11M | 106.21M | 103.17M | 107.65M | 116.57M |
| Deferred Income Tax | (24.68M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 2.69M | 2.62M | 3.3M | 3.01M | 3.45M |
| Change in Working Capital | 10.35M | 5K | (2.87M) | (3.46M) | (5.37M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 15.75M | 650K | (2.11M) | 1.44M | 245K |
| Other Working Capital | (5.4M) | (645K) | (760K) | (4.9M) | (5.62M) |
| Other Non-Cash Items | 4.66M | 804K | (56.04M) | 5.23M | (13.78M) |
| Operating Cash Flow | 84.03M | 91.99M | 89.52M | 98.25M | 98.45M |
| Capital Expenditures | (35.88M) | (56.57M) | (58.83M) | (56.65M) | (34.16M) |
| Acquisitions (Net) | 328.06M | 161.32M | 0 | 0 | 0 |
| Purchases of Investments | (292.18M) | (104.67M) | 0 | 0 | 0 |
| Sales of Investments | 33.82M | 41K | 223.26M | 18.83M | 132.77M |
| Other Investing Activities | (301.04M) | (160.09M) | 120.21M | (69.54M) | (159.63M) |
| Investing Cash Flow | (267.23M) | (160.09M) | 120.21M | (50.72M) | (26.87M) |
| Debt Repayment | 113.12M | 108.07M | (140.25M) | 6.5M | 10.79M |
| Common Stock Issued | 156.04M | 31.44M | 0 | 112.07M | 0 |
| Common Stock Repurchased | 0 | (33.2M) | (11.58M) | (4.7M) | (4.63M) |
| Dividends Paid | (45.56M) | (51.53M) | (50.81M) | (51.25M) | (51.56M) |
| Other Financing Activities | (9.09M) | (13.41M) | (9.72M) | (9.25M) | (23.66M) |
| Financing Cash Flow | 214.51M | 41.37M | (212.35M) | (43.67M) | (69.06M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 31.32M | (26.73M) | (2.62M) | 3.86M | 2.52M |
| Free Cash Flow | 48.15M | 35.42M | 30.7M | 41.59M | 64.29M |
Centerspace
NYSE:CSR
Intrinsic Alpha fair value
Locked
Current Price
$56.12
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.